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Summary
Objective: To review the current South American literature on classic Kaposi’s
sarcoma (KS) and human herpesvirus 8 (HHV-8), and point the way for studies that
still need to be performed.
Materials and methods: The authors performed an exhaustive search in LILACS,
SCIELO and PUBMED databases for classic KS and HHV-8 in South America. The relevant
material was evaluated and reviewed.
Results: More than 250 cases have been reported with three big case series (Argen-
tina, Colombia and Peru). The classic KS form seen in Colombia resembles the type of
disease seen among African communities; the same unusual presentation with con-
fluent exophytic nodules or eroded lesions has been noticed in Peru. Low rates of HHV-
8 antibodies have been found in blood donors from Chile, Argentina and Brazil (3%, 4%,
2.8—7.4%, respectively); whereas high rates of HHV-8 antibodies have been found in
Amerindians from Brazil and Ecuador. Five specimens from Argentina were subtyped:
(three classic KS and two AIDS KS); the identified strains fell into subtypes A and C.
AIDS-related KS specimens from Brazil and Venezuela were subtyped: (43 and nine
respectively); analysis grouped them predominantly into subgroups A, B and C. A new
HHV-8 subtype E was found endemic in Brazilian and Ecuadorian Amerindians. In
French Guiana ten endemic KS and six AIDS-related KS specimens were subtyped;
analysis grouped them predominantly into subgroups A, B and C.* Corresponding author. Tel.: +511 475 0573; fax: +511 265 3646.
E-mail address: salim17@yahoo.com (S. Mohanna).
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Kaposi’s sarcoma (KS) was first described in 1872 by
Moriz Kaposi.1 Kaposi’s sarcoma has been classified
into four clinical-epidemiological variants. These
variants include the original classic KS, African or
endemic KS, iatrogenic or immunosuppression-
related KS, and epidemic or AIDS-related KS. Classic
KS occurs predominantly among elderly people,
with a higher incidence in southern and eastern
European countries, with a predominance among
Jews, Italians and Greeks.2
In 1994, Chang et al.3 identified by representa-
tional-difference analysis DNA sequences of a new
herpesvirus, homologous to Epstein Bar virus and
Herpes virus Saimiri, named Kaposi’s sarcoma her-
pesvirus or human herpesvirus 8 (HHV-8). Since
then, HHV-8 DNA sequences have been detected
in almost all KS lesions analyzed, whether endemic,
classic, iatrogenic or epidemic.4
HHV-8 is not found uniformly throughout the
world’s population as is the case for most other
human herpesviruses.5 The spread of the virus among
the human population varies widely depending
on the geographical region. Low HHV-8 seropreva-
lence rates (0—5%) were found in northern Europe,
Asia and North America; intermediate HHV-8 sero-
prevalence rates (5—20%) were reported in the
Mediterranean, Eastern European, and Caribbean
countries; and high HHV-8 seroprevalence rates
(>50%) were detected in central and southern
Africa.6 Molecular epidemiological studies have
revealed that HHV-8 has a highly variable open read-
ing frame (ORF) K1 gene at the left end of its genome,
and that this variability makes the K1 gene a very
good marker for HHV-8 genotyping and strain differ-
entiation.7 Six major molecular subtypes of the K1
gene have been described from specimens obtained
around the world. The first subtypes to be
identified were A, B, C, and D, followed by subtypes
E and N.8—12
This article reviews the data that has been gen-
erated by investigators through South America and
draws conclusions from the present body of knowl-edge, as well as shows where the data are still
controversial, and leads the way for studies that
still need to be performed.Materials and methods
An exhaustive bibliographic search was performed
on LILACS, SCIELO and PUBMED databases on records
up until December 2004. The authors searched ori-
ginal articles, case series, case reports, and letters
to editors concerning classic KS and HHV-8 in South
America (Argentina, Bolivia, Brazil, Chile, Colom-
bia, Ecuador, French Guiana, Guyana, Paraguay,
Peru, Suriname, Uruguay, and Venezuela). Likewise,
non-indexed journals and doctoral theses that con-
tained information about these topics were also
searched. All relevant material was evaluated and
reviewed.Results
Peru
In 1968 Paredes-Pacheco and Albu´jar13 reported the
first case of classic KS. The patient was a 58-year-old
indigenous male with purple nodules on his arms and
legs. In 1985 Maita et al.14, with the purpose of
evaluating the immunoperoxidase method in the
search for factor VIII antigen, reported 27 cases
(21 male, six female) of classic KS found between
1968 and 1982. Patients ranged from 22 to 81-years-
old. Most of them presented with multiple lesions
(81.5%). The most common sites of presentation
were the lower and upper limbs with ulcerated
and hyperkeratotic lesions. There was one case on
the trunk, one on the stomach, one on the breast
and one with disseminated lesions. Seven cases
presented with edema in the lower limbs. In
1998, Valverde and Albu´jar15 reported two cases
of classic KS with unusual characteristics in Trujillo.
The first patient was a 51-year-old male with a
nodule on his right index finger. The second patientConclusion: Classic KS in South America has a very similar clinical presentation but
not the same as the classic KS variety described in the Mediterranean. Initial
seroprevalence studies performed in the general population and in blood donors
showed low seroprevalence of HHV-8, whereas high seroprevalence rates were seen in
Amerindian population. The existing serological assays, nonetheless, need to be
further refined, and new assays need to be developed. Finally, the key to under-
standing the precise molecular epidemiology and phylogenetic distribution of HHV-8
in South America would be to perform more subtyping of classic KS cases.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
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thumb. Among the 4305 cases of malignant neopla-
sia registered between 1984 and 1990 in the Trujillo
Metropolitan Cancer Registry, three were found to
be classic KS cases.8
In 1996 Echegaray et al.16 reviewed the clinical
records from 81 patients with KS diagnosis (62 with
classic KS and 19 with AIDS-related KS) between
1949 and 1994 at the National Cancer Center of
Lima (INEN as per its Spanish abbreviation). The
mean age of the patients was 64.1 years, with a
male-female ratio of 3:1. Pain and edema were
present in 34 (55%) patients. Forty-three patients
(62%) had KS lesions localized on lower limbs and 16
patients (16%) had a diffuse presentation. Twenty-
four patients (39%) had one lesion, whereas 38 (61%)
had multiple lesions. Ten patients (16%) presented
with eroded lesions. Five percent of patients had
a past medical history of sexually transmitted
diseases (STD). No reference was made to the place
of origin and background of these patients. In 1997
Cano17 reviewed 22,863 records for the period
1991—1995 from the pathology department of Hos-
pital Nacional Cayetano Heredia. He found 29 cases
of KS, making it the third most common malignant
tumor (14.87%). There was no information regarding
clinical presentation, ethnic origin or immune
status of these patients. Finally, in 2004 Mohanna
et al. (in press) reported the unusual presentation
of a 53-year-old indigenous patient (Quechua)
with purplish-brown nodular lesions in the lower
extremities, miliary and central nervous system
tuberculosis. ELISA-HIV tests were negative and
immunohistochemistry (IHC) of the tumor tissue
was positive for HHV-8. This was the first case in
Peru where HHV-8 was found in KS lesions through
immunohistochemical techniques.
Venezuela
In 1995 Essenfeld de Sekler et al.18 reported one case
of classic KSwith pulmonary involvement in an immu-
nocompetent patient. In 2003 Hernandez et al.19
reported the molecular characterization of nine
AIDS-related KS specimens. The results showed sub-
type B in five patients (56%), subtype C in three
patients (33%), and subtype A in one patient (11%).
Patients represented a mixed population that
developed as a result of the intermixing of several
generations of Spaniards, Indians, and blacks.
Ecuador
In 2004 Whitby et al.20 reported that in Ecuadorian
Amerindians, the Huaorani had a high prevalence of
antibodies against HHV-8, with 38 of 38 subjectsreacting in both the latent nuclear antigen (LNA)
immunofluorescence assay (IFA) and LNA ELISA,
while 24/38 (63%) were positive in the K8.1 assay.
The Siona people had a lower prevalence of anti-
bodies to LNA by IFA (10/41, 24%) and ELISA (8/41,
20%) and to K8.1 (10/41, 24%). Ecuadorians of Afri-
can descent had the lowest prevalence, with 11/80
(14%) being positive for K8.1, 14/80 (17.5%) by LNA
ELISA and 10/80 (12.5%) by LNA IFA. K1 sequence
was obtained from three Huaorani and two Siona
subjects. All sequences were characterized as sub-
type E, based on K1 analysis. Ecuadorian sequences
formed a separate branch within the subtype E
grouping and the Huaorani and Siona sequences
clustered separately within this branch. All strains
had the P allele of K15. They obtained a T0.7
sequence from an African Ecuadorian; this sequence
was clearly characterized as subtype B.
Colombia
In 1989 Garcia et al.21 reported 79 cases of classic KS
seen at the National Institute of Cancer, Bogota´,
from 1935 to 1985. Those cases represented 5% of all
soft tissue sarcomas and approximately 1% of all
malignant tumors. There were 70 men and nine
women, with a male-female ratio of 8:1. The mean
age of the patients was 65 years. Fifty-nine patients
(74%) belonged to the 61 to 80 years-old age group.
Most of them were white or mestizo patients of low
socioeconomic status and the majority were farm-
ers. The mean time of evolution of the disease
before consultation was 1.7 years. Fifty-five
patients (70%) had nodules, whereas 25 had patches
and nodules (32%) and these were occasionally con-
fluent and exophytic. Twenty-two patients (28%)
had eroded lesions, most of which were bleeding
ulcers. Leg, foot, or hand edema associated with the
KS lesions was the main finding in 38 patients (48%).
Satellite inguinal adenopathies were found in 18
patients (23%). No black patients were seen, but
the classic KS form seen in their patients resembles
the type of disease seen among African commu-
nities.
Brazil
In 1986 Fagundes et al.22 reported one case of
classic KS associated with mycosis fungoides in a
65-year-old male. In 1998 Alonso et al.23 reported
seven cases of classic KS on which they reviewed
histopathology and immunohistochemical aspects.
In 2001 Costa et al.24 reported one case of classic KS.
In 2002, Arnone et al.25 reported one case of dis-
seminated classic KS in a 68-year-old male. In 1998
Caterino-de-Araujo26 reported the molecular char-
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AIDS-related KS patients from Sao Paulo. Three
patients were of Italian origin, three of Portuguese
origin, and one of Arabian origin. Analysis of HHV-8
Brazilian isolates grouped them predominantly into
groupsB andC. In 1998Zhanget al.27 reporteda study
where nine of 14 homosexual men HIV-positive/KS-
positive (64%) were seropositive by IFA for LNA of
HHV-8. In 1999 Caterino-de-Araujo28 reported the
seroprevalence of HHV-8 in a small group of blood
donors. They used IFA for LNA, and found that six of
81 blood donors (7.4%) were seropositive.
In 2000, Zago et al.29 reported that HHV-8 anti-
bodies were detected in a low frequency in blood
donors (4.6%) and in patients attending casualty
departments (9.6%). In the HIV-negative group from
the STD/AIDS clinics, HHV-8 antibodies were present
in only 3.7% of patients. In contrast, a higher fre-
quency of antibodies was observed in the HIV-posi-
tive/KS-positive group (80%) and in the HIV-
positive/KS-negative group (14.6%). All serum sam-
ples were analyzed by an IFA method to the LNA of
HHV-8. In the same year, Biggar et al.30 using an IFA
test for LNA demonstrated that the prevalence of
HHV-8 in 781 Amerindians of diverse tribes (overall
53% prevalence) was not related to language group
or sex, but rather increased gradually from 41% in
children <10 years of age to 65% in adults 30 years
of age. In IFA positive subjects, HHV-8 DNA was
detected in three (16%) of 19 mononuclear cell
samples from peripheral blood. K1 was amplified
from blood samples from two of the three PCR
positive subjects, using nested PCR, and samples
were sequenced. The Amerindian K1 sequences
were 95% identical to each other, but they differed
from previously reported A, B, C and D subtype HHV-
8 K1 sequences by 25—30%. Thus, a new HHV-8
subtype, E, is hyper-endemic in Brazilian Amerin-
dians, although KS has not been reported.
In 2001 Keller et al.31 reported the seroprevalence
of HHV-8 on HIV-positive patients. Using PCR, 74.4%
(29/39) of the KS-positive patients and 3.7% (1/27) of
the KS-negative patients were positive for the KS330
sequence. LNA and lytic assays detected the same
number of HHV-8 positive patients in each group, 31
(79.5%) in the KS-positive group and five (18.5%) in
the KS-negative group; of these, 24 (77.4%) and three
(60%), respectively, were detected by both antigens.
Thirty-eight (97.4%) of the KS patients were found to
be HHV-8 seropositive by both serological tests. In
2002 Freitas et al.32 reported a seroprevalence study
in normal populations inhabiting two neighboring,
crowded districts of northern Brazil. Detection of
IgG antibodies to HHV-8 was done using a commercial
ELISA. Overall, 16.3% (81/497) of tested persons had
HHV-8 antibody, with prevalence rates increasingfrom 12—33.3% across age groups. Similar prevalence
rateswere found forwomenandmen (18.4% and 14%,
respectively). In 2002 Zong et al.33 reported the
molecular characterization of three AIDS-related
KS cases from Brazil. The results showed A1, A8,
and C3 subtypes.
In 2003 Caterino-de-Araujo34 reported a seropre-
valence study performed in women from Sao Paulo.
The first group was comprised of 163 HIV-positive
women; they presented an overall HHV-8 antibody
frequency of 8.6%, a 1.2% frequency of anti-latent
antibodies and an 8% frequency of anti-lytic antibo-
dies. The second groupwas comprised of 108 children
born to HIV-positive mothers; they presented an
overall frequency of 7.4% HHV-8 antibodies, ranging
from 10.9—0%. A 10.9% frequency of HHV-8 antibody
was detected among HIV-positive children, and an
8.3% frequency was observed in children with unde-
fined HIV status. The third group was comprised of
630 HIV-negative healthy women; they presented an
overall HHV-8 antibody frequency of 1.3%, a 1.1%
frequency of anti-latent antibodies and a 0.3% fre-
quency of anti-lytic antibodies. In the same year,
Caterino-de-Araujo and Lopes Cibella35 reported a
study that searched for HHV-8 antibodies in plasma
samples from children born to HIV-infected mothers
from Sao Paulo. All plasma samples were tested by an
IFA LNA and IFA to lytic antigens. No cases of anti-
latent antibodies were detected, contrasting with
the 7.4% of anti-lytic antibodies detected among
children born to HIV-infectedmothers. High frequen-
cies of HHV-8 antibodies were detected in confirmed
HIV-infected children (6/55; 10.9%) and in children
with undefined HIV status (2/24; 8.3%). In contrast,
no cases of HHV-8 positive antibodies were detected
among HIV-negative children (0/29).
In 2004 Nascimento et al.36 reported the mole-
cular characterization of 33 AIDS-related KS speci-
mens from Sao Paulo. Nineteen patients reported
their ethnicity to be Caucasian, nine reported Afri-
can descent, four reported mixed origin, and one
patient was of Amazonian descent. Only three of the
major HHV-8 subtypes were detected, with 48%,
21%, and 30% of patients harboring subtypes A, B,
and C. In the same year, Souza et al.37 reported a
seroprevalence study performed in 643 healthy chil-
dren and young adults from the general population
in ten different areas in Sao Paulo, all in high risk
groups for HHV-8 infection. They found an overall
seroprevalence of 2.5% among healthy children and
adults from the general population using lytic IFA.
No cases were found positive using the LNA IFA. For
high risk groups they found 32.6% seroprevalence of
HHV-8 in HIV negative homosexuals; 39.2% in HIV-
positive/KS-negative patients; and, 98.7% in HIV-
positive/KS-positive patients, using lytic or LNA IFA.
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study performed in 319 blood samples obtained from
Campinas, Sao Paulo. They found an overall sero-
prevalence of 2.8% (3.8% in males and 0% in females)
using IFA for lytic antibodies.
Argentina
In 1983 Eigelman et al.39 reported four cases of KS. In
1985Paternoetal.40 reported tencasesofKS inwhich
factor VIII was demonstrated by immunohistochem-
ical techniques. In 1989 Nudenberg41 reported a 73-
year-oldmalewith classic KS characterizedby lesions
on the trunk, lower andupper limbs. Partial remission
was obtained after radiotherapy. In 1994, Freuler
et al.42 reported KS in two middle-aged males with-
out evidence of HIV infection. The first patient pre-
sented with nephrotic syndrome; after treatment he
developed fever and diffuse lymphadenopathies.
Biopsies revealed KS and Castleman’s disease. Serol-
ogy for HIV proved negative several times. The sec-
ond patient was admitted with sepsis caused by
Proteus mirabilis and died 48 hours later. Serology
for HIV proved negative. Necropsy revealed KS on his
knee and liver.
In 1998 Bacchiocchi and Brusco43 reviewed the
clinical records of 42 patients with classic KS
observed during the previous 25 years at the Hospi-
tal Privado de la Comunidad de Mar del Plata. Those
42 cases comprised 0.01% of dermatological consul-
tations and 0.0005% of general consultations.
Patients ranged from 51 to 86-years-old, with a
male-female ratio of 1:1. The background was
obtained for 34 patients: 24 were Italian, seven
were Spanish, two Polish, one Jewish and eight
Argentines. Multiple lesions were presented in
42.9% of patients. Most of them presented with
nodular lesions (85.7%). Lower limbs were affected
in 83.3% of patients. Ulceration was presented in
31%, edema in 23.8% and pain in 2.4%. A second
primary malignancy was noted in 11.9%. During the
6.5 years of follow up, no deaths were associated
with classic KS.
In 2001 Feinsilber et al.44 reported six patients
with classic KS treated with intralesional interferon
with no complications. In the same year, Meng
et al.45 reported the molecular characterization
of five specimens of KS (three classic KS and two
AIDS-related KS). Two of the identified strains fell
into subtype I/A and three in subtype II/C. The two
subtype I/A strains were more divergent within the
subtype, with one falling into each of the two main
subtypes I/A clades. The three subtype II/C strains
clustered relatively closely within one of the two
main II/C clades. Two of the classic KS patients had
European origins.In the same year Sosa et al.46 reported seropre-
valence of HHV-8 among HIV-positive IVDUs, and HIV-
negative IVDUs and non-IVDUs by an in-house IFA.
Among the HIV-positive IVDUs, 25/144 (17.36%)
were HHV-8 positive. In the HIV-negative IVDUs,
11.1% were HHV-8 positive. In contrast, HHV-8 ser-
oprevalence in HIV-negative non-IVDUs was 5.71%.
In 2004, Perez et al.38 reported an overall ser-
oprevalence of 4% (3.6% in males, and 4.9% in
females) performed in 1859 blood samples obtained
from blood banks from three different geographic
regions: Buenos Aires (4.3%), Bahia Blanca (2.4%),
and Cordoba (3.4%). They used IFA for lytic anti-
bodies.
Chile
In 1992 Fich and Moraga47 reported one case of
classic KS in a 33-year-old male with nodules and
plaques on lower limbs. Moncayo et al.48 reported
four cases of classic KS between 1979 and 1994. In
2004 Perez et al.38 reported a seroprevalence study
performed in 300 blood samples obtained from the
blood bank of the Hospital Clinico J.J. Aguirre,
Santiago de Chile. They found an overall seropre-
valence of 3% (2.5% in males, and 3.8% in females)
using IFA for lytic antibodies.
French Guiana
In 2000 Fouchard et al.4 reported the molecular
characterization of seven specimens of KS (five
endemic KS and two epidemic KS). They performed
sequence analysis for fragments of gene coding for
the capsid protein (ORF26) and the tegument pro-
tein (ORF75). By subtyping the fragment of ORF26,
they found that two strains belonged to subtype B
and the remainder to subtype C. Surprisingly,
sequence analysis of the ORF75 fragment only
revealed the A or the C subtype, with several minor
variants (A00, A000 and C). They mentioned that the
low level of genomic diversity is similar (1—2%) in
subtypes A, B and C when considering ORF26 and
ORF75.
In 2000 Plancoulaine et al.49 reported a seropre-
valence study to evaluate HHV-8 transmission from
mother to child and between siblings. They
included 1337 individuals that belonged to Noir-
Marron, descendants from slaves of African origin.
The overall HHV-8 seroprevalence was 13.2%, with
no significant difference between sexes. All plasma
samples were tested by IFA. In the same year
Lacoste et al.50 reported the molecular character-
ization of ten specimens of KS (four AIDS-related
KS, five endemic KS, and one iatrogenic KS). Ana-
lysis revealed three of the major subtypes (A, B and
244 S. Mohanna et al.C). In 2002 Plancoulaine et al.51 reported a sero-
prevalence study to evaluate the influence of age
and gender on anti-HHV-8 antibody titers among
HHV-8 seropositive subjects in an endemic popula-
tion. The study included 1819 subjects with an
overall HHV-8 seroprevalence of antibodies against
lytic antigens of 11.8%. Among the 214 HHV-8
seropositive subjects, anti-HHV-8 antibody titers
were found to strongly increase with age and were
statistically significantly higher in males than in
females.
No information was obtained for classic KS or
HHV-8 in Bolivia, Uruguay, Paraguay, Guyana or
Suriname.
Discussion
Classic KS has been described in the literature as
occurring predominantly in elderly men of Jewish,
eastern European, or Mediterranean descent. In
countries where seroprevalence of HHV-8 has been
studied, data show that HHV-8 is not ubiquitous in
general healthy human populations as is the case
with other human herpesviruses.5 Due to this parti-
cular distribution of HHV-8 in the world, a strongFigure 1 Distribution of classic KS cases, HHV-8 sdirect correlation between HHV-8 prevalence and
classic KS occurrence has been shown by numerous
studies. There are some exceptions, for example in
Africa, where endemic juvenile KS is found in
Uganda and Zambia, but not in Gambia or Ivory
Coast even though all four countries have similar
seroprevalence of antibodies to HHV-8. Likewise, in
Alexandria (Egypt), Papua New Guinea, and in areas
of China, the prevalence of HHV-8 is high, but KS
prevalence is low.52—54 Something similar has been
described in Brazilian Amerindians, who had a
high prevalence (53%), although KS has not been
reported. This finding could suggest that some
cofactors might be necessary for the development
of KS, or it could be caused by some genetic pre-
disposition.
This review shows that more than 250 cases have
been reported, with three big case series (Argen-
tina, Colombia and Peru) demonstrating that classic
KS is a prevalent pathology in South America
(Figure 1). The oldest series in South America was
reported in Colombia in 1935, followed by the
Peruvian series in 1949. An interesting clinical
observation from Colombia is that the classic KS
seen in their patients resembles the type of disease
seen amongAfrican communities. The sameunusualubtypes and seroprevalence in South America.
Epidemiology and clinical characteristics of classic Kaposi’s sarcoma 245
Table 1 HHV-8 seroprevalence studies in South America.
Country Reference Group No. tested (positive %) Test method
Ecuador 20 Huaorani Amerindians 38 (100%) BCP-1 LNA IFA
38 (100%) LNA ELISA
38 (63%) K 8.1
Siona Amerindians 41 (24%) BCP-1 LNA IFA
41 (20%) LNA ELISA
41 (24%) K 8.1
Ecuadorians of African descent 80 (12.5%) BCP-1 LNA IFA
80 (17.5%) LNA ELISA
80 (14%) K 8.1
Chile 38 Blood donors 300 (3%) Lytic BCBL-1 IFA
Argentina 38 Blood donors 1851 (4%) Lytic BCBL-1 IFA
46 HIV pos/IVDU 144 (17.36%) BCBL-1 IFA
HIV neg/IVDU 9 (11.1%) BCBL-1 IFA
HIV neg/non-IVDU 70 (5.71%) BCBL-1 IFA
French Guiana 49 General population 1337 (13.2%) IFA
51 General population 1819 (11.8%) Lytic IFA
Brazil 27 Homosexuals HIV pos/KS pos 14 (64%) LNA IFA
28 Blood donors 81 (7.4%) BCP-1 LNA IFA
29 Blood donors 747 (4.6%) BCP-1 LNA IFA
Casualty department patients 73 (9.6%) BCP-1 LNA IFA
HIV neg from STD clinic 136 (3.7%) BCP-1 LNA IFA
HIV pos/KS pos 40 (80%) BCP-1 LNA IFA
HIV pos/KS neg 48 (14.6%) BCP-1 LNA IFA
30 Amerindians 781 (53%) BCP-1 LNA IFA
31 HIV pos/KS pos 39 (74.4%) PCR
HIV pos/KS neg 27 (3.7%) PCR
HIV pos/KS pos 39 (79.5%) LNA IFA & Lytic IFA
HIV pos/KS neg 27 (18.5%) LNA IFA & Lytic IFA
32 General population 497 (16.3%) ELISA
34 HIV pos women 163 (1.2%) IFA and WB LNA
HIV pos women 163 (8%) Lytic IFA
Children born to HIV pos mother 108 (7.4%) Lytic IFA
HIV neg healthy women 630 (1.3%) IFA & WB LNA
HIV neg healthy women 630 (0.3%) Lytic IFA
35 Children born to HIV pos mother 108 (7.4%) BCBL-1 Lytic IFA
Children born to HIV pos mother 108 (0%) BCBL-1 LNA IFA
37 Healthy children and young adults 643 (2.5%) Lytic IFA
Healthy children and young adults 0 LNA IFA
Homosexuals HIV neg 95 (21.1%) Lytic IFA
Homosexuals HIV neg 95 (20%) LNA IFA
HIV pos/KS neg 130 (34.6%) Lytic IFA
HIV pos/KS neg 130 (24.6%) LNA IFA
HIV pos/KS pos 78 (97.4%) Lytic IFA
HIV pos/KS pos 78 (75.6%) LNA IFA
38 Blood donors 319 (2.8%) BCBL-1 Lytic IFA
IVDU: intra venous drug users; LNA: latent nuclear antigen; IFA: immunofluorescence assay; WB: western blot; Lytic: lytic antigen;
BCP-1: cell line used as source of HHV-8; BCBL-1: cell line used as source of HHV-8; K8.1: lytic phase glycoprotein.
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Table 2 Molecular characterization of Kaposi’s sarcoma in South America.
Country Reference Specimen Sex Age Origin Biopsy K1
Venezuela 19 AIDS KS M NS Mixeda Skin B
AIDS KS M NS Mixeda Skin B
AIDS KS M NS Mixeda Skin B
AIDS KS M NS Mixeda Skin B
AIDS KS M NS Mixeda Skin and Mucosa B
AIDS KS M NS Mixeda Skin C
AIDS KS M NS Mixeda Skin C
AIDS KS M NS Mixeda Skin and Mucosa C
AIDS KS M NS Mixeda Skin A
Argentina 45 AIDS KS M 40 Argentine Skin I/A
AIDS KS M 42 Argentine Skin II/C
Classic KS M 82 Caucasian Skin II/C
Classic KS M 75 Caucasian Skin II/C
Classic KS F 71 Argentine Skin I/A
Ecuador 20 Blood NS NS Huaorani — E
Blood NS NS Huaorani — E
Blood NS NS Huaorani — E
Blood NS NS Siona — E
Blood NS NS Siona — E
Blood NS NS African Ecuadorian — Bb
French Guiana 4 Endemic KS M 78 African Skin C
Endemic KS M 59 African Skin C
Endemic KS M 75 African Skin C/A00 c
Endemic KS F 37 African Skin B0/A000 c
AIDS KS M 33 African Skin C0/Cc
AIDS KS M 78 African Skin B0/A000 c
Endemic KS M 52 African Skin C
50 AIDS KS M 33 African Skin B2
AIDS KS M 53 African Skin B1
AIDS KS F 37 African Skin A
AIDS KS F 53 African Skin B1
Endemic KS M 78 African Skin C
Endemic KS M 75 African Skin A5
Endemic KS M 78 African Skin B3
Iatrogenic KS M 62 African Skin A5
Endemic KS M 61 African Skin B1
Endemic KS M 70 African Skin B1
Brazil 26 AIDS KS F 67 Italian Lung C/Bd
AIDS KS M 43 Portuguese Lymph node C/Bd
AIDS KS M NS Italian Skin C/Bd
AIDS KS M 32 Arabian Skin B/Cd
AIDS KS M NS Portuguese Skin B/Ad
AIDS KS M NS Portuguese Skin B/Cd
AIDS KS M 29 Portuguese Skin Other/Otherd
30 Blood M 64 Arawete — E
Blood F 66 Asurini — E
33 AIDS KS NS NS Caucasian NS A1
AIDS KS NS NS Caucasian NS A8
AIDS KS NS NS Caucasian NS C3
36 AIDS KS M African Skin B0
AIDS KS M Mulatto Skin A000
AIDS KS M Amerindian Skin A5
AIDS KS M Mulatto Skin/Lung A0
AIDS KS M Caucasian Lung B1
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Table 2 (Continued )
Country Reference Specimen Sex Age Origin Biopsy K1
AIDS KS M Caucasian Lung C0
AIDS KS M Caucasian Lung C2
AIDS KS M African Skin A00
AIDS KS F Mulatto Skin C3
AIDS KS M African Skin A1
AIDS KS M Caucasian Skin C2
AIDS KS F Caucasian Skin/GI C3
AIDS KS M Caucasian GI A0
AIDS KS M Mulatto Lung B0
AIDS KS M Caucasian Skin A0
AIDS KS M Caucasian Skin C3
AIDS KS M Caucasian Skin B1
AIDS KS M Caucasian Lung C0
AIDS KS M African Skin C0
AIDS KS M Caucasian GI B1
AIDS KS M Caucasian GI A0
AIDS KS M Caucasian Skin A00
AIDS KS M Caucasian Skin C3
AIDS KS M Caucasian GI C3
AIDS KS M African Skin B0
AIDS KS M Caucasian Skin B0
AIDS KS M African Skin A0
AIDS KS M Caucasian Skin A´
AIDS KS M African Skin A0
AIDS KS M Caucasian Skin/GI A5
AIDS KS M African Skin A0
AIDS KS M Caucasian Skin A1
AIDS KS M African Skin A6
M: male; F: female; NS: not specified; GI: gastro-intestinal. Caucasian: white European descendant; African: black African
descendant; Mulatto: mixed African/Caucasian descendant.
a Population that developed as a result of the intermixing of several generations of Spaniards, Indians, and blacks.
b This subtype was characterized from a T0.7 sequence.
c They performed sequence analysis of fragments of genes ORF26 and ORF75.
d HHV-8 subgroups according to Di Alberti et al.60 and Zong et al.8.presentation with confluent exophytic nodules or
eroded lesions has been noticed in Peru. Likewise,
reports from Colombia and Peru characteristically
mention that KS cases presented in indigenous or
mestizo populations, whereas cases from Argentina
more generally presented in European descendents.
It is important to note that classic KS distribution
is probably underdiagnosed and underreported
because it occurs in areas of the continent with
extremely low socioeconomic conditions.
This classic KS incidence must correlate with
HHV-8 presence in the continent. Most seropreva-
lence studies carried out to date in South America
have focused on groups with an increased risk of
acquiring HHV-8 infection, instead of the general
population or localized populations where classic KS
has been described (Table 1). An important contri-
bution has been made by studies performed on
Brazilian and Ecuadorian Amerindians, where
results have demonstrated high frequency rates ofHHV-8. Studies performed on blood donors from
Chile, Brazil, and Argentina have demonstrated
similar low frequency rates of HHV-8.
As can be seen in this study, one of the most
important problems with seroprevalence studies is
the difference in reported HHV-8 seroprevalence
rates. This may be the result of different laboratory
algorithms, sera dilutions (1:10 to 1:160) and the
assays used. Serological tests measure antibodies to
latent or lytic antigens by IFA; against recombinant
structural proteins, synthetic peptides, or whole
virus by enzyme immunoassays or Western blots.7
There is no gold standard for HHV-8 because the
virus cannot be reliably cultured. As immunofluor-
escence assays that detect lytic antigens are gen-
erally more sensitive than other assays, their
use results in higher estimates of prevalence.55
The existing serological assays, nonetheless, need
to be further refined and new assays need to be
developed.
248 S. Mohanna et al.Another important step in the acknowledgement
of the global spread of HHV-8 is the molecular char-
acterization of its variants. Six major molecular sub-
types of HHV-8 have been reported based on the
highly variable K1 gene. Interestingly, these subtypes
have been found to correlate very strongly with
geographic and ethnic backgrounds. Subtypes A
and C are found in Europe, the USA and Australia,
whilst subtype C alone predominates across Asia.
Subtypes B and A5 are found mainly in Africa and
French Guiana. Subtype D has been reported in
Aboriginals of the Pacific rim, including Taiwan, Aus-
tralia and Japan. Subtype E has been found among
Amerindian populations of the Brazilian and Ecuador-
ian Amazon regions. Subtype N, has been identified
only in South Africa.4,8,9,11,20,30,45,50,56—59
Some of these subtypesmay have co-evolved with
certain human populations. The most plausible
explanation for this pattern is the theory that mod-
ern humans migrated out of Africa in three major
waves producing the separation of the main
branches. The first migration spread across sub-
Saharan Africa beginning 100,000 years ago (subtype
B). The second went to south Asia and ultimately
Australia, Taiwan and the Pacific Islands, beginning
60,000—70,000 years ago (subtype D). The third
migration with separate branches to Europe and
north Asia initially occurred 35,000 years ago (sub-
types A and C), with later expansion into the Amer-
icas (subtype E) approximately 15,000 years ago and
northern Europe 10,000 years ago at the end of the
last Ice Age.33
This raises interesting questions as to the origin of
the virus in different populations of South America.
The few specimens reported and the fact that
almost all of them were AIDS-related KS cases does
not give precise information about the origin of the
virus in the continent, except for the E Amerindians
subtype (Table 2). More genotyping of the virus
present in patients with classic KS, especially in
Amerindians, could be extremely helpful in answer-
ing this question and should be the next step.
With all this information it can be concluded that
classic KS in South America has a very distinct
clinical presentation, but differs from the classic
KS variety described in the Mediterranean. This
should be analyzed with more retrospective studies
on areas where classic KS has been described, and
used to perform a comparative analysis of KS within
the region to determine whether South America has
its own endemic type of KS.
Countries like Colombia and Peru must perform
HHV-8 seroepidemiological studies to corroborate
pocket zones of HHV-8 as they have reported several
cases of classic KS in the indigenous population.
Initial seroprevalence studies performed on thegeneral population and on blood donors showed
low seroprevalences of HHV-8, whereas high sero-
prevalence rates were seen in the Amerindian popu-
lation.
Finally, the key to understanding the precise
molecular epidemiology and phylogenetic distribu-
tion of HHV-8 in South America would be to perform
more subtyping of these classic KS cases.
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